Drug Trial News

RSS

Combination therapy reduces tumor resistance to radiation

Radiation is used to treat a variety of tumors and the response of tumors to radiation is dependent on endothelial cell death, which in turn limits oxygen delivery to the tumor, causing hypoxia and tumor cell death.

8 Jun 2007

Endocannabinoids appear to play important role in regulating inflammation

Endocannabinoids seem to play an important role in regulating inflammation processes. Scientists from the University of Bonn have discovered this in experiments on mice.

8 Jun 2007

Novel pathways and markers for diagnosis and treatment of bipolar disorder

Looking into the brain is yielding vital clues to understanding, diagnosing and treating bipolar disorder, according to findings being presented at the Seventh International Conference on Bipolar Disorder.

8 Jun 2007

Weight regain in U.S. adults who experienced substantial weight loss

Every so often, another study comes out depicting the average American as an incorrigible yo-yo dieter and committed couch potato; however, nearly six in 10 people maintained their weight loss to within 5 percent over a year's time in a new study from the Centers for Disease Control and Prevention.

8 Jun 2007

Folic acid does not prevent colorectal cancer

Despite the fact that some previous studies have suggested that folate supplementation may help to prevent colorectal cancer, a new study says that is not the case and it may in fact increase the risk for some types of colorectal tumors.

6 Jun 2007

Dieters need to exercise to retain that weight loss

According to a new national survey in the U.S., despite the widely held belief that most dieters see their weight swing up and down after dieting, many Americans do maintain their weight loss.

6 Jun 2007

Ecstasy damages parts of the brain

Ecstasy, the illicit drug loved by party people and dance club patrons, may harm parts of the brain involved with verbal memory, according to new research.

5 Jun 2007

Antipsychotic drugs used to treat dementia shorten life

A new Canadian study by a geriatric medicine specialist has found that the antipsychotic drugs used to treat some of the disruptive behaviours of older adults with dementia may shorten the patient's life.

5 Jun 2007

Marriage a cure for depression?

Many people out there - especially some men will find the latest research on depression laughable......lift your depression by getting married!

5 Jun 2007

Steroid use among teen girls

Steroid use among teen girls is not limited to those involved in competitive athletics and is associated with a cluster of other health-harming behaviors, including smoking and taking diet pills, according to results of a national survey published in the June issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

5 Jun 2007

Low doses of Ecstasy associated with decreased verbal memory function

Even low doses of Ecstasy may be associated with a decline in language-related memory, according to a report in the June issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jun 2007

Hypothyroidism linked to mood swings

Hypothyroidism is often associated with mood changes like depression lethargy.

5 Jun 2007

Moderate strengthening exercises may slow progression of Lou Gehrig's disease

Moderate strengthening exercises may help people with early stage ALS maintain function and quality of life longer, according to a study published in the June 5, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

5 Jun 2007

Do pay-for-performance incentives improve quality of care?

Pay-for-performance incentives have been proposed as a method to improve the quality of care received by patients.

5 Jun 2007

After epilepsy surgery, quality of life related more to seizures than memory

Epilepsy surgery can eliminate seizures for 60 to 85 percent of people with temporal lobe epilepsy who do not respond well to medications.

5 Jun 2007

VEGF Trap (aflibercept) shows activity in patients with advanced ovarian cancer

Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.

5 Jun 2007